Cargando…
On/off-switchable anti-neoplastic nanoarchitecture
Throughout the world, there are increasing demands for alternate approaches to advanced cancer therapeutics. Numerous potentially chemotherapeutic compounds are developed every year for clinical trial and some of them are considered as potential drug candidates. Nanotechnology-based approaches have...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586894/ https://www.ncbi.nlm.nih.gov/pubmed/26415561 http://dx.doi.org/10.1038/srep14571 |
_version_ | 1782392442023051264 |
---|---|
author | Patra, Hirak K. Imani, Roghayeh Jangamreddy, Jaganmohan R. Pazoki, Meysam Iglič, Aleš Turner, Anthony P. F. Tiwari, Ashutosh |
author_facet | Patra, Hirak K. Imani, Roghayeh Jangamreddy, Jaganmohan R. Pazoki, Meysam Iglič, Aleš Turner, Anthony P. F. Tiwari, Ashutosh |
author_sort | Patra, Hirak K. |
collection | PubMed |
description | Throughout the world, there are increasing demands for alternate approaches to advanced cancer therapeutics. Numerous potentially chemotherapeutic compounds are developed every year for clinical trial and some of them are considered as potential drug candidates. Nanotechnology-based approaches have accelerated the discovery process, but the key challenge still remains to develop therapeutically viable and physiologically safe materials suitable for cancer therapy. Here, we report a high turnover, on/off-switchable functionally popping reactive oxygen species (ROS) generator using a smart mesoporous titanium dioxide popcorn (TiO(2) Pops) nanoarchitecture. The resulting TiO(2) Pops, unlike TiO(2) nanoparticles (TiO(2) NPs), are exceptionally biocompatible with normal cells. Under identical conditions, TiO(2) Pops show very high photocatalytic activity compared to TiO(2) NPs. Upon on/off-switchable photo activation, the TiO(2) Pops can trigger the generation of high-turnover flash ROS and can deliver their potential anticancer effect by enhancing the intracellular ROS level until it crosses the threshold to open the ‘death gate’, thus reducing the survival of cancer cells by at least six times in comparison with TiO(2) NPs without affecting the normal cells. |
format | Online Article Text |
id | pubmed-4586894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-45868942015-09-30 On/off-switchable anti-neoplastic nanoarchitecture Patra, Hirak K. Imani, Roghayeh Jangamreddy, Jaganmohan R. Pazoki, Meysam Iglič, Aleš Turner, Anthony P. F. Tiwari, Ashutosh Sci Rep Article Throughout the world, there are increasing demands for alternate approaches to advanced cancer therapeutics. Numerous potentially chemotherapeutic compounds are developed every year for clinical trial and some of them are considered as potential drug candidates. Nanotechnology-based approaches have accelerated the discovery process, but the key challenge still remains to develop therapeutically viable and physiologically safe materials suitable for cancer therapy. Here, we report a high turnover, on/off-switchable functionally popping reactive oxygen species (ROS) generator using a smart mesoporous titanium dioxide popcorn (TiO(2) Pops) nanoarchitecture. The resulting TiO(2) Pops, unlike TiO(2) nanoparticles (TiO(2) NPs), are exceptionally biocompatible with normal cells. Under identical conditions, TiO(2) Pops show very high photocatalytic activity compared to TiO(2) NPs. Upon on/off-switchable photo activation, the TiO(2) Pops can trigger the generation of high-turnover flash ROS and can deliver their potential anticancer effect by enhancing the intracellular ROS level until it crosses the threshold to open the ‘death gate’, thus reducing the survival of cancer cells by at least six times in comparison with TiO(2) NPs without affecting the normal cells. Nature Publishing Group 2015-09-29 /pmc/articles/PMC4586894/ /pubmed/26415561 http://dx.doi.org/10.1038/srep14571 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Patra, Hirak K. Imani, Roghayeh Jangamreddy, Jaganmohan R. Pazoki, Meysam Iglič, Aleš Turner, Anthony P. F. Tiwari, Ashutosh On/off-switchable anti-neoplastic nanoarchitecture |
title | On/off-switchable anti-neoplastic nanoarchitecture |
title_full | On/off-switchable anti-neoplastic nanoarchitecture |
title_fullStr | On/off-switchable anti-neoplastic nanoarchitecture |
title_full_unstemmed | On/off-switchable anti-neoplastic nanoarchitecture |
title_short | On/off-switchable anti-neoplastic nanoarchitecture |
title_sort | on/off-switchable anti-neoplastic nanoarchitecture |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586894/ https://www.ncbi.nlm.nih.gov/pubmed/26415561 http://dx.doi.org/10.1038/srep14571 |
work_keys_str_mv | AT patrahirakk onoffswitchableantineoplasticnanoarchitecture AT imaniroghayeh onoffswitchableantineoplasticnanoarchitecture AT jangamreddyjaganmohanr onoffswitchableantineoplasticnanoarchitecture AT pazokimeysam onoffswitchableantineoplasticnanoarchitecture AT iglicales onoffswitchableantineoplasticnanoarchitecture AT turneranthonypf onoffswitchableantineoplasticnanoarchitecture AT tiwariashutosh onoffswitchableantineoplasticnanoarchitecture |